Search Results

Lone Star Bio

Saranas Reveals Groundbreaking SAFE-MCS Study Results at CRT 2024

Saranas, Inc. announced today the compelling results of SAFE-MCS, a multi-center clinical study evaluating the safety of complex high-risk percutaneous coronary intervention (PCI) using mechanical circulatory support (MCS) and surveillance with the Early Bird ® Bleed Monitoring System (EBBMS).

March 11, 2024

·

4 min read

Lone Star Bio

Saranas Successfully Completes Enrollment of Clinical Trial Assessing the Utility of Early Bleed Detection in Patients Undergoing Mechanical Circulatory Support

Saranas, Inc. announced today that it has completed enrollment in SAFE-MCS, a multi-center, single arm, open-label clinical trial evaluating the safety of complex high-risk percutaneous coronary intervention (PCI) using mechanical circulatory support.

September 18, 2023

·

4 min read

Business

Saranas Appoints Mike MacKinnon as CEO

Saranas® Inc., a medical device company focused on improving patient outcomes through early detection and monitoring of internal bleeding complications, announced the hiring of seasoned medtech executive, Mike MacKinnon, as Chief Executive Officer.

February 27, 2023

·

4 min read

Lone Star Bio

Saranas Reaches Midpoint for Enrollment in Clinical Trial Assessing the Utility of Early Bleed Detection in Patients Undergoing Mechanical Circulatory Support

Saranas, Inc. announced today that it has reached the midpoint for enrollment in SAFE-MCS, a multi-center, single arm, open-label clinical trial evaluating the safety of complex high-risk percutaneous coronary intervention (PCI) using mechanical circulatory support (MCS).

March 27, 2023

·

4 min read

Lone Star Bio

Saranas Announces Over 1,200 Patients Treated with the Early Bird® Bleed Monitoring System

Saranas, Inc. announced today that over 1,200 patients have been treated with the Early Bird® Bleed Monitoring System, the first and only FDA-approved bleed detection system.

November 9, 2022

·

3 min read

Lone Star Bio

Saranas® Receives Innovative Technology Contract from Vizient

Saranas announced its Early Bird Bleed Monitoring System has received an Innovative Technology contract from Vizient, Inc., the nation’s largest member-driven health care performance improvement company.

April 7, 2022

·

3 min read

Lone Star Bio

Saranas® Expands Intellectual Property with Key Patent Integrating Bleed Monitoring and Vascular Access Closure Device

Saranas, a company focused on improving patient outcomes through early detection and monitoring of internal bleeding complications, announced today that the U.S. Department of Commerce’s United States Patent and Trademark Office (USPTO) has issued them Patent No. 11,224,414.

February 23, 2022

·

2 min read

Lone Star Bio

Saranas® Announces Initial Enrollment of Clinical Trial Assessing the Utility of Early Bleed Detection in Patients Undergoing Mechanical Circulatory Support

Saranas, Inc., has announced initiation and first patient enrollment in SAFE-MCS, a multi-center, single arm, open-label clinical trial evaluating the safety of complex high-risk percutaneous coronary intervention using mechanical circulatory support and surveillance with the Early Bird Bleed Monitoring System.

December 6, 2021

·

4 min read

BioMidwest

Saranas Awarded Technology Breakthroughs Contract With Premier

Saranas, Inc., developer of the Early Bird® Bleed Monitoring System designed for early detection of internal bleed complications during endovascular procedures, has been awarded a group purchasing agreement with Premier Inc., as part of Premier’s Technology Breakthroughs program.

September 29, 2020

·

2 min read

Job Trends

Saranas Recognized as One of Houston’s Most Innovative Companies

Saranas Inc. announced that it has been named one of Houston’s most innovative companies.

August 15, 2019

·

1 min read